DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/aa1022/target_product_pro) has announced the addition of Decision Resources, Inc.'s new report Target Product Profiles 2010: Physician Insights on Key Attributes: Rheumatoid Arthritis to their offering. Rheumatoid Arthritis: A disease-modifying drug with a novel mechanism of ...

Chelsea Therapeutics International, Ltd. announced confirmation by the US Food and Drug Administration (FDA) that its proposed phase II protocol for CH-4051 in rheumatoid arthritis has been approved by the agency.

HUNDREDS of NSW victims of the arthritis drug Vioxx could miss out on compensation because they have not registered for a class action, lawyers Slater Gordon say.

Australians who had a heart attack after taking the arthritis drug Vioxx have just weeks to join a class action against the drug's maker.

The worlds largest pharmaceutical company made misrepresentations and concealed documents from BYU in ongoing $1 billion litigation over creation of the arthritis drug Celebrex, according to an amended complaint filed this month in U.S. District Court in Salt Lake City. BYU and biochemistry professor Daniel Simmons first filed the lawsuit against Pfizer in 2006, alleging that Pfizer predecessor ...